Evaluation of performance of human immunodeficiency virus antigen/antibody combination assays in Taiwan

Cohen, 2001, Pathogenesis and medical aspects of HIV Infection, 2043 UNAIDS, 2012 Centers for Disease Control, Taiwan, 2013 Centers for Disease Control, Taiwan, 2013 Lee, 2000, Determination of human immunodeficiency virus type 1 subtypes in Taiwan by vpu gene analysis, J Clin Microbiol, 38, 2468, 10.1128/JCM.38.7.2468-2474.2000 Chen, 2001, Temporal trends and molecular epidemiology of HIV-1 infection in Taiwan from 1988 to 1998, J Acquir Immune Defic Syndr, 26, 274, 10.1097/00126334-200103010-00011 Lin, 2006, An epidemic of HIV type I CRF07_BC infection among injection drug users in Taiwan, J Acquir Immune Defic Syndr, 42, 248, 10.1097/01.qai.0000214818.80539.da Chang, 2006, Molecular epidemiology of HIV type 1 subtypes in Taiwan: outbreak of HIV type 1 CRF07_BC infection in intravenous drug users, AIDS Res Hum Retroviruses, 22, 1055, 10.1089/aid.2006.22.1055 Kao, 2011, Surveillance of HIV type 1 recent infection and molecular epidemiology among different risk behaviors between 2007 and 2009 after the HIV type 1 CRF07_BC outbreak in Taiwan, AIDS Res Hum Retroviruses, 27, 745, 10.1089/aid.2010.0244 Montaner, 2010, Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study, Lancet, 376, 532, 10.1016/S0140-6736(10)60936-1 Cohen, 2011, Prevention of HIV-1 infection with early antiretroviral therapy, N Engl J Med, 365, 493, 10.1056/NEJMoa1105243 Vasudevachari, 2002, Principles and procedures of human immunodeficiency virus serodiagnosis, 790 Kwon, 2006, Performance evaluation of three automated human immunodeficiency virus antigen–antibody combination immunoassays, J Virol Methods, 133, 20, 10.1016/j.jviromet.2005.10.013 Huang, 2005, Acute human immunodeficiency virus infection, J Microbiol Immunol Infect, 38, 65 Ly, 2004, Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays, J Virol Methods, 122, 185, 10.1016/j.jviromet.2004.08.018 Sickinger, 2004, Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen, J Clin Microbiol, 42, 21, 10.1128/JCM.42.1.21-29.2004 Weber, 1998, Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays, J Clin Microbiol, 36, 2235, 10.1128/JCM.36.8.2235-2239.1998 Ly, 2001, Seven human immunodeficiency virus (HIV) antigen–antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection, J Clin Microbiol, 39, 3122, 10.1128/JCM.39.9.3122-3128.2001 Brust, 2000, Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test, J Virol Methods, 90, 153, 10.1016/S0166-0934(00)00229-9 Weber, 2002, Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO ultra, J Clin Microbiol, 40, 1420, 10.1128/JCM.40.4.1420-1426.2002 Miedouge, 2011, Analytical sensitivity of four HIV combined antigen/antibody assays using the p24 WHO standard, J Clin Virol, 50, 57, 10.1016/j.jcv.2010.09.003 Song, 2012, Performances of four fourth-generation human immunodeficiency virus-1 screening assays, J Med Virol, 84, 1884, 10.1002/jmv.23423 Weber, 2003, HIV seroconversion: performance of combined antigen/antibody assays, AIDS, 17, 931, 10.1097/00002030-200304110-00024 Bentsen, 2011, Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma, J Clin Virol, 52, S57, 10.1016/j.jcv.2011.09.023 Karris, 2012, Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection, J Clin Microbiol, 50, 1874, 10.1128/JCM.00106-12 Patel, 2006, Detection of acute HIV infections in high-risk patients in California, J Acquir Immune Defic Syndr, 42, 75, 10.1097/01.qai.0000218363.21088.ad Gurtler, 1998, Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay, J Virol Methods, 75, 27, 10.1016/S0166-0934(98)00094-9 Ly, 2007, Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?, J Virol Methods, 143, 86, 10.1016/j.jviromet.2007.02.013 Chen, 2006, HIV-1 CRF07_BC infections, injecting drug users, Taiwan, Emerg Infect Dis, 12, 703, 10.3201/eid1204.050762 Cheng, 1993, Five-year experience of human immunodeficiency virus type 1 national screening program implemented at Veterans General Hospital—Taipei, Zhonghua Yi Xue Za Zhi (Taipei), 55, 71 Shida, 2011, False-positive human immunodeficiency virus antibody test and autoimmune hemolytic anemia in a patient with angioimmunoblastic T-cell lymphoma, Intern Med, 50, 2383, 10.2169/internalmedicine.50.5764 Proffitt, 1993, Laboratory diagnosis of human-immunodeficiency-virus infection, Infect Dis Clin N Am, 7, 203, 10.1016/S0891-5520(20)30519-5 Cordes, 1995, Pitfalls in HIV testing. Application and limitations of current tests, Postgrad Med, 98, 177, 10.1080/00325481.1995.11946078 Chen, 2007, Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants, J Formos Med Assoc, 106, 148, 10.1016/S0929-6646(09)60231-X Tseng, 2012, Seroprevalence of hepatitis virus infection in men who have sex with men aged 18–40 years in Taiwan, J Formos Med Assoc, 111, 431, 10.1016/j.jfma.2011.06.022 Chang, 1997, Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children, N Engl J Med, 336, 1855, 10.1056/NEJM199706263362602 Chang, 2011, Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan, J Clin Microbiol, 49, 1083, 10.1128/JCM.01154-10 Cohen, 2010, The detection of acute HIV infection, J Infect Dis, 202, S270, 10.1086/655651 Fiebig, 2003, Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection, AIDS, 17, 1871, 10.1097/00002030-200309050-00005 Pandori, 2009, Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting, J Clin Microbiol, 47, 2639, 10.1128/JCM.00119-09 Eshleman, 2009, Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay, J Acquir Immune Defic Syndr, 52, 121, 10.1097/QAI.0b013e3181ab61e1 Bourlet, 2005, Comparative evaluation of the VIDAS HIV DUO Ultra assay for combined detection of HIV-1 antigen and antibodies to HIV, J Virol Methods, 127, 165, 10.1016/j.jviromet.2005.03.011